Track the 바이오인프라 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 바이오인프라 has logged 12 reports. The latest transaction was reported on 8 June 2026 (Purchase). Among the most active insiders: 김장현. Every trade is openly available.
12
Insider Decl.
n/a
Thresholds
n/a
5 ops.
Buy Volume
n/a
7 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
BioInfra es una empresa especializada en el sector de la salud y farmacéutico, que cotiza en el mercado XKRX. Se enfoca en el desarrollo de soluciones innovadoras para mejorar la salud humana.